Groowe BETA / Newsroom

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Lantern Pharma (Nasdaq: LTRN) Establishes Open-Medicine AI as a Separate Company to Commercialize and Expand Its Multi-Agent AI Co-Scientist Platform for the Transformation of Medicine

businesswire.com August 3, 2026 at 6:30 AM ET

LTRN Lantern Pharma is establishing its AI platform, Open-Medicine AI, as a separate company. This move aims to commercialize and expand the platform, which could be positive for future growth, but the immediate impact on Lantern Pharma's stock is not specified.